Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease
Authors:
- Jacqueline Pérez-PazosJPJacqueline Pérez-Pazos
- Asunción García-SánchezAGAsunción García-Sánchez
- Miguel EstravísMEMiguel Estravís
- Emma Moreno-JimenezEMEmma Moreno-Jimenez
- Natalia MorgadoNMNatalia Morgado
- Manuel Gómez-GarcíaMGManuel Gómez-García
- Cristina Martín-GarcíaCMCristina Martín-García
- Francisco Muñoz-BellidoFMFrancisco Muñoz-Bellido
- Catalina SanzCSCatalina Sanz
- María Isidoro-GarcíaMIMaría Isidoro-García
Open Access
- 11 April 2024
- journal article
- research article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Abstract
Introduction: Type 2 (T2) asthma is often associated with chronic rhinosinusitis with nasal polyposis (CRSwNP). Additionally, nonsteroidal anti-inflammatory drug (NSAID) intolerance leads to NSAID-exacerbated respiratory disease (N-ERD). Previous transcriptomic data in non-CRSwNP T2 asthma patients showed differentially expressed genes. We focused onALOX15,CLC,CYSLTR2,HRH4andSMPD3to investigate their role in T2 asthma.Methods: The study included 100 healthy controls and 103 T2 asthma patients, divided into patients with asthma (n=54), patients with asthma and CRSwNP (n=29) and patients with N-ERD (n=20). Quantitative PCR analysis was performed on blood-derived RNA samples first to validate the five differentially expressed genes. The data were further analysed to find potential associations and biomarkers.Results: Patients, regardless of stratification, exhibited significantly higher gene expression than healthy controls. The patterns of association revealed thatALOX15was exclusively present in the non-comorbidity group,SMPD3andCLCin the comorbidity groups, andHRH4in all patient groups.ALOX15,CYSLTR2andSMPD3expression showed potential as biomarkers to confirm the diagnosis of T2 asthma using peripheral blood eosinophils as the initial criterion. Peripheral blood eosinophils combined with gene expression, especiallySMPD3, may improve the diagnosis.CLCandCYSLTR2expression play a specific role in discriminating N-ERD.Discussion: We validated the transcriptomic data of five differentially expressed genes in T2 asthma. Different patterns of association were identified in patient stratification, suggesting that different molecular mechanisms underlie the spectrum of T2 asthma. Potential biomarkers were also found and used to design an algorithm with practical diagnostic utility for T2 asthma, including risk stratification for N-ERD.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2021-125117OB-I00)
- Junta de Castilla y León (IES161P20)
- Instituto de Salud Carlos III (IMP/00009, PI20/00268, PMP22/00124, RD21/0002/0054)
This publication has 36 references indexed in Scilit:
- Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association StudiesFrontiers in Pharmacology, 2016
- Nasal polyps in patients with asthma: prevalence, impact, and management challengesJournal of Asthma and Allergy, 2016
- Is the H4 receptor a new drug target for allergies and asthmaFrontiers in Bioscience-Elite, 2013
- Neutral Sphingomyelinase 2American Journal of Respiratory Cell and Molecular Biology, 2011
- A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthmaPharmacogenetics, 2004
- Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophilsClinical & Experimental Allergy, 2001
- Molecular Cloning and Characterization of a New Human Histamine Receptor, HH4RBiochemical and Biophysical Research Communications, 2000
- Natural history of aspirin-induced asthmaEuropean Respiratory Journal, 2000
- Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthmaEuropean Respiratory Journal, 2000
- Likelihood Ratio: A Powerful Tool for Incorporating the Results of a Diagnostic Test Into Clinical DecisionmakingAnnals of Emergency Medicine, 1999